Alnylam Pharmaceuticals Inc (ALNY)
244.89
-1.91
(-0.77%)
USD |
NASDAQ |
Nov 22, 16:00
246.38
+1.49
(+0.61%)
After-Hours: 20:00
Alnylam Pharmaceuticals Cash from Financing (Quarterly): 102.76M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 102.76M |
| June 30, 2024 | 131.50M |
| March 31, 2024 | 28.91M |
| December 31, 2023 | 39.23M |
| September 30, 2023 | 33.14M |
| June 30, 2023 | 53.39M |
| March 31, 2023 | 46.37M |
| December 31, 2022 | 63.44M |
| September 30, 2022 | 297.02M |
| June 30, 2022 | 30.34M |
| March 31, 2022 | 34.96M |
| December 31, 2021 | 292.29M |
| September 30, 2021 | 573.84M |
| June 30, 2021 | 329.81M |
| March 31, 2021 | 51.18M |
| December 31, 2020 | 217.95M |
| September 30, 2020 | 34.15M |
| June 30, 2020 | 689.01M |
| March 31, 2020 | 53.87M |
| December 31, 2019 | 40.34M |
| September 30, 2019 | -20.70M |
| June 30, 2019 | 412.61M |
| March 31, 2019 | 390.93M |
| December 31, 2018 | 5.378M |
| September 30, 2018 | 12.99M |
| Date | Value |
|---|---|
| June 30, 2018 | 5.581M |
| March 31, 2018 | 41.52M |
| December 31, 2017 | 706.95M |
| September 30, 2017 | 28.92M |
| June 30, 2017 | 386.31M |
| March 31, 2017 | 2.716M |
| December 31, 2016 | 3.082M |
| September 30, 2016 | 4.346M |
| June 30, 2016 | 154.34M |
| March 31, 2016 | 16.07M |
| December 31, 2015 | 6.468M |
| September 30, 2015 | 3.651M |
| June 30, 2015 | 7.074M |
| March 31, 2015 | 598.98M |
| December 31, 2014 | 7.658M |
| September 30, 2014 | 4.794M |
| June 30, 2014 | 5.138M |
| March 31, 2014 | 718.88M |
| December 31, 2013 | 7.65M |
| September 30, 2013 | 11.08M |
| June 30, 2013 | 3.982M |
| March 31, 2013 | 178.21M |
| December 31, 2012 | 0.966M |
| September 30, 2012 | 4.499M |
| June 30, 2012 | 0.628M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
28.91M
Minimum
Mar 2024
689.01M
Maximum
Jun 2020
157.17M
Average
53.63M
Median
Cash from Financing (Quarterly) Benchmarks
| Pfizer Inc | -4.636B |
| BridgeBio Pharma Inc | 0.707M |
| Gilead Sciences Inc | -1.379B |
| Johnson & Johnson | -9.882B |
| Biomarin Pharmaceutical Inc | -499.12M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 43.71M |
| Cash from Investing (Quarterly) | -30.25M |
| Free Cash Flow | 16.06M |
| Free Cash Flow Per Share (Quarterly) | 0.3073 |
| Free Cash Flow to Equity (Quarterly) | 38.55M |
| Free Cash Flow to Firm (Quarterly) | 41.80M |
| Free Cash Flow Yield | 0.05% |